Latest filing published 12 Nov 2025 for Codexis, INC., €80k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +29.4%Entry US$2.11 · Close at T+365 US$2.73
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephen George Dilly: trading record in brief
Stephen George Dilly has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Aimmune Therapeutics, Inc., Codexis, Inc. and Sangamo Therapeutics, Inc. We count 74 filings; the first trade dates from 25 July 2016 and the latest from 11 November 2025.
Market trades split into 2 purchases (€168k) and 30 sales (€18.7M). Taken together, the sales exceed the purchases by €18.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 12 share grants and 9 option exercises.
On 12 November 2025 came the latest disclosure, a share grant for €80k in Codexis, Inc. The last purchase on record was published on 12 September 2023, which is 1,154 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen George Dilly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$1.8473100.0% of flowCommon StockSEC:0001610717-25-000374:0
- 88,750 shares0Common StockSEC:0000905148-25-000438:0
- 143,425 shares0Common StockSEC:0000905148-24-000029:0
- 58,479 shares@ US$1.7263100.0% of flowCommon StockSEC:0000905148-23-000900:0Canonical exit: 7 Dec 2023 (T+90)
- 28,088 shares@ US$4.6029.4% of flowCommon StockSEC:0001567619-23-004772:1
- 26,987 shares@ US$4.5628.3% of flowCommon StockSEC:0001567619-23-004772:2
- 289,000 shares0Common StockSEC:0001567619-23-004772:0
- 112,500 shares0Common StockSEC:0001567619-23-003441:0
- 5,000 shares@ US$55.0078.2% of flowCommon StockSEC:0001209191-22-040252:0
- 11,273 shares0Common StockSEC:0001567619-22-012978:0
- 4,796 shares0Common StockSEC:0001567619-21-012328:0
- 5,000 shares@ US$17.8321.8% of flowCommon StockSEC:0001209191-21-034601:0Canonical exit: 17 Aug 2021 (T+90)
- 17,905 shares0Common StockSEC:0001567619-20-012365:0
- 10,000 shares0Common StockSEC:0001209191-20-034015:0
- 2,500 shares0Common StockSEC:0001209191-20-030948:0
- 35,000 shares@ US$5.42Common StockSEC:0001209191-20-020483:0
- 35,000 shares@ US$6.00Common StockSEC:0001209191-20-020483:1
- 15,000 shares@ US$5.42Common StockSEC:0001209191-20-020143:0
- 15,000 shares@ US$6.02Common StockSEC:0001209191-20-020143:1
- 2,500 shares0Common StockSEC:0001209191-19-036440:0
- 29,457 shares@ US$3.020.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-016350:0
- 29,457 shares@ US$30.834.1% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-016350:1
- 2,500 shares0Common StockSEC:0001209191-18-037345:0
- 30,465 shares@ US$3.020.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-015796:0
- 30,465 shares@ US$31.204.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-015796:1
25 of 74 declarations
